சூரியன் பார்மா ஆய்வகங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சூரியன் பார்மா ஆய்வகங்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சூரியன் பார்மா ஆய்வகங்கள் Today - Breaking & Trending Today

AstraZeneca Pharma India terminates distribution services agreement with Sun Pharma


AstraZeneca Pharma India announced that in 2016 the company had entered into a distribution services agreement with Sun Pharma Laboratories (Sun Pharma) for the distribution of Dapagliflozin, an innovative Type 2 diabetes medicine, in India. Under the said Agreement, Sun Pharma promoted and distributed Dapagliflozin under the brand name Oxra.
Sun Pharma also gained the rights to promote and distribute the combination of Dapagliflozin with Metformin under the brand name Oxramet and the combination of Dapagliflozin and Saxagliptin under the brand name Oxraduo.
Now, AstraZeneca India and Sun Pharma have discontinued its existing Distribution Services Agreement signed in 2016 by entering into a Transition Supply Agreement with effect from 28 May 2021. Under the Transition Supply Agreement, Sun Pharma will continue to promote and distribute Dapagliflozin and the combinations of Dapagliflozin with Metformin under the brand Oxra and Oxramet until such period of time as mutually ....

Sun Pharma , Forxiga Xigduo , Distribution Services Agreement , Astrazeneca Pharma India , Sun Pharma Laboratories , Astrazeneca India , Transition Supply Agreement , Zeneca India , Capital Market , Anti Diabetic Drugs , Chemical Compounds , Sglt2 Inhibitors , Combination Drugs , Bristol Myers Squibb , Sun Pharma , Harmaceuticals Nec , Astrazeneca Pharma India , சூரியன் பார்மா , சூரியன் பார்மா ஆய்வகங்கள் , ஸெநெக இந்தியா , மூலதனம் சந்தை ,